COMMUNIQUÉS West-GlobeNewswire

bioLytical Laboratories Earns MDSAP Certification, Highest Quality Standard in Medical Device Industry
21/02/2019
Audits confirm bioLytical’s Quality Management System fulfils latest standards for multiple regulatory jurisdictions including US FDA and Health Canada. RICHMOND, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- [...]
4 Companies Shaping The CBD-Infused Beverage Industry
21/02/2019
VANCOUVER, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- With the global CBD movement supercharged by the 2018 U.S. Farm Bill , cannabis and beverage companies alike are officially beginning to launch CBD-infused [...]
Agritek Holdings, Inc. Announces Upcoming CEO Webcast Interview Discussing Initial Order of 25,000 Units With Colorado's Top Selling Cannabis Edibles Brand, Mountain High Suckers, for Puerto Rico Through Exclusive Licensee 1919 Clinic
21/02/2019
LOS ANGELES, CA, Feb. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and brand licensor for the [...]
Catalyst Pharmaceuticals Responds to Letter from Senator Bernie Sanders
21/02/2019
CORAL GABLES, Fla., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Alphatec to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 7, 2019
21/02/2019
CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”) announced today that the Company plans to release its fourth quarter and fiscal year 2018 [...]
Amgen, Cytokinetics and Servier Announce Start of METEORIC-HF, the Second Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
21/02/2019
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES, France, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Amgen (NASDAQ: AMGN), Cytokinetics, Incorporated (NASDAQ: CYTK) and Servier today announced that METEORIC-HF [...]
Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
21/02/2019
DTX401 Response in Time to Hypoglycemia and Improved Glucose Control Maintained or Improved in All Three Patients Data from Higher-dose Cohort 2 Expected Mid-2019 NOVATO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- [...]
Ziopharm Oncology CEO to Present at the CAR-TCR Summit Europe
21/02/2019
BOSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that Chief Executive Officer Laurence Cooper, M.D., Ph.D, is scheduled to present and participate in a panel discussion on [...]
With a Strategic Investment by Aleafia Health, Aura Health Announces Increase to Previously Announced Brokered Subscription Receipt Financing to $7.26 Million
21/02/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Feb. 21, 2019 ( [...]
Aduro Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference
21/02/2019
BERKELEY, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, is scheduled to present at the 8 [...]
Cognition Therapeutics Receives European Patent Covering its Alzheimer's Disease Candidate, Elayta™
21/02/2019
Pittsburgh, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative diseases and [...]
Genocea to Host Quarterly Corporate Update Conference Call & Webcast on February 28 at 9:00 am ET
21/02/2019
CAMBRIDGE, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it will host a conference [...]
HTG Molecular to Present Corporate Overview at the Cowen & Company 39th Annual Health Care Conference
21/02/2019
TUCSON, Ariz., Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief [...]
Zogenix to Release Fourth Quarter and Full-Year 2018 Financial Results and Host Conference Call and Webcast on February 28
21/02/2019
EMERYVILLE, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the [...]
GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference
21/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 8th Annual SVB Leerink Global Healthcare Conference in New [...]
Chiesi Joins National Organization for Rare Disorders (NORD)® Corporate Council
21/02/2019
Partnership supports Chiesi USA presence in global rare disease market CARY, N.C., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee), a specialty pharmaceutical company, and the National Organization for Rare [...]
Intra-Cellular Therapies to Present at the 8th Annual SVB Leerink Global Healthcare Conference
21/02/2019
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Achaogen Announces Publication of Plazomicin Phase 3 CARE Study Results in the New England Journal of Medicine
21/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]
Axovant to Host First R&D Day March 29, 2019
21/02/2019
NEW YORK and BASEL, Switzerland, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that it will host its first R&D Day [...]

Pages